Psoriasis Completed Phase 2 Trials for Masitinib (DB11526)
Also known as: Psoriasis unspecified / Psoriasis, unspecified
| Indication | Status | Phase |
|---|---|---|
| DBCOND0013339 (Psoriasis) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01045577 | A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis | Treatment |